These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changes in insulin, somatostatin, and glucagon secretion during the development of obesity in ventromedial hypothalamic-lesioned rats. Seino Y, Seino S, Takemura J, Tsuda K, Nishi S, Ishida H, Seno M, Usami M, Ikeda M, Imura H. Endocrinology; 1984 Feb; 114(2):457-61. PubMed ID: 6140160 [Abstract] [Full Text] [Related]
3. Possible involvement of the cholinergic system in hormonal secretion by the perfused pancreas from ventromedial-hypothalamic lesioned rats. Rohner-Jeanrenaud F, Jeanrenaud B. Diabetologia; 1981 Mar; 20(3):217-22. PubMed ID: 6112185 [Abstract] [Full Text] [Related]
5. Consequences of ventromedial hypothalamic lesions upon insulin and glucagon secretion by subsequently isolated perfused pancreases in the rat. Rohner-Jeanrenaud F, Jeanrenaud B. J Clin Invest; 1980 Apr; 65(4):902-10. PubMed ID: 6987269 [Abstract] [Full Text] [Related]
6. Effect of a high-protein diet on insulin and glucagon secretion in ventromedial hypothalamic (VMH) lesioned rats. Usami M, Seino Y, Takemura J, Seino S, Nakahara H, Ikeda M, Matsukura S, Imura H. J Nutr Sci Vitaminol (Tokyo); 1985 Jun; 31(3):355-61. PubMed ID: 3906052 [Abstract] [Full Text] [Related]
14. Effects of imidazoline derivative RX871024 on insulin, glucagon, and somatostatin secretion from isolated perfused rat pancreas. Efanova IB, Zaitsev SV, Efanov AM, Ostenson C, Raap A, Mest H, Berggren P, Efendi. Biochem Biophys Res Commun; 1998 Nov 09; 252(1):162-5. PubMed ID: 9813163 [Abstract] [Full Text] [Related]
15. Somatostatin, insulin and glucagon secretion by the perfused pancreas from the cysteamine-treated rat. Silvestre RA, Miralles P, Moreno P, Villanueva ML, Marco J. Biochem Biophys Res Commun; 1986 Feb 13; 134(3):1291-7. PubMed ID: 2868720 [Abstract] [Full Text] [Related]
16. The interaction of vasoactive intestinal polypeptide (VIP), glucose and arginine on the secretion of insulin, glucagon and somatostatin in the perfused rat pancreas. Szecówka J, Sandberg E, Efendić S. Diabetologia; 1980 Aug 13; 19(2):137-42. PubMed ID: 6106616 [Abstract] [Full Text] [Related]
17. Inhibition by somatostatin of glucagon and insulin release from the perfused rat pancreas in response to arginine, isoproterenol and theophylline: evidence for a preferential effect on glucagon secretion. Gerich JE, Lovinger R, Grodsky GM. Endocrinology; 1975 Mar 13; 96(3):749-54. PubMed ID: 1116481 [Abstract] [Full Text] [Related]
18. Theophylline: potentiation of arginine-induced somatostatin release from the isolated rat pancreas. Goto Y, Seino Y, Taminato T, Kadowaki S, Chiba T, Note S, Imura H. Diabetes; 1979 May 13; 28(5):457-9. PubMed ID: 437374 [Abstract] [Full Text] [Related]
19. Effects of rat pancreatic polypeptide on islet-cell secretion in the perfused rat pancreas. Dégano P, Peiró E, Miralles P, Silvestre RA, Marco J. Metabolism; 1992 Mar 13; 41(3):306-9. PubMed ID: 1347399 [Abstract] [Full Text] [Related]
20. Somatostatin release from the isolated, perfused diabetic rat pancreas: inverse relationship between pancreatic somatostatin and insulin. Kadowaki S, Taminato T, Chiba T, Goto Y, Nozawa M, Seino Y, Matsukura S, Fujita T. Diabetes; 1980 Dec 13; 29(12):960-3. PubMed ID: 6108269 [Abstract] [Full Text] [Related] Page: [Next] [New Search]